...
首页> 外文期刊>Journal of chemotherapy >In vitro synergy of colistin combinations against extensively drug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase
【24h】

In vitro synergy of colistin combinations against extensively drug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase

机译:大肠菌素组合对广泛耐药的鲍曼不动杆菌产生OXA-23碳青霉烯酶的体外协同作用

获取原文
获取原文并翻译 | 示例
           

摘要

Fifty extensively drug-resistant Acinetobacter baumannii (XDRAB) were isolated from patients. The chequerboard microdilution method was used to determine the in vitro activities of five colistin (COL)based combinations including COL+fosfomycin (FOS), COL+rifampicin (RIF), COL+imipenem (IMP), COL+sulbactam (SUP) and COL+levofloxacin (LVX). The synergistic activity was evaluated by the fractional inhibitory concentration index (FICI). According to our results, the combination of COL was synergistic with FOS, RIF, IMP, SUP and LVX with the ratios of 50, 72, 88, 92 and 64%, respectively. When combined with COL, the other five agents showed increased antimicrobial activities. In addition, two of the combinations, COL+RIF and COL+IMP, were more active than the combinations of COL+FOS, COL+SUP and COL+LVX. More importantly, these combination regimens could exert synergistic effects at the sub-minimum inhibitory concentration (MIC) levels against XDRAB strains.
机译:从患者中分离出五十种广泛耐药的鲍曼不动杆菌(XDRAB)。棋盘微稀释法用于确定五种基于大肠菌素(COL)的组合的体外活性,包括COL +磷霉素(FOS),COL +利福平(RIF),COL +亚胺培南(IMP),COL +舒巴坦(SUP)和COL +左氧氟沙星(LVX)。通过分数抑制浓度指数(FICI)评估协同活性。根据我们的结果,COL与FOS,RIF,IMP,SUP和LVX的协同作用分别为50%,72%,88%,92%和64%。当与COL结合使用时,其他五种药物显示出增加的抗菌活性。另外,两种组合,COL + RIF和COL + IMP,比COL + FOS,COL + SUP和COL + LVX组合更具活性。更重要的是,这些组合方案可以在针对XDRAB菌株的次最低抑制浓度(MIC)水平上发挥协同作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号